Earnings History Data for Krystal Biotech, Inc. (KRYS) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
Krystal Biotech, Inc.
Krystal Biotech, Inc. is a gene therapy company. It engaged in developing and commercializing novel treatments for patients suffering from dermatological diseases. Krystal Biotech, Inc. is based in Pittsburgh, United States.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 04-11-2024 | PM | KRYS | Krystal Biotech, Inc. | 4,960 | 0.91 | 0.84 | -0.67 | Krystal Biotech GAAP EPS of $0.91 beats by $0.01, revenue of $83.84M beats by $0.73M [11/4/2024 8:04 AM] |
170.56 | -5.83 (-3.31%) |
166.50 | -9.89 (-5.61%) |
93.95 - 219.34 | 674,942 | 150,000 | 6,254 | ||
|
||||||||||||||||||
| 05-08-2024 | PM | KRYS | Krystal Biotech, Inc. | 5,680 | 0.86 | 0.50 | -1.25 | Krystal Biotech GAAP EPS of $0.53 misses by $0.06, revenue of $70.28M beats by $4.82M [8/5/2024 8:04 AM] |
180.72 | -11.22 (-5.85%) |
165.00 | -26.94 (-14.04%) |
93.95 - 219.34 | 943,145 | 300,000 | 7,541 | ||
| 06-05-2024 | PM | KRYS | Krystal Biotech, Inc. | 4,530 | 0.03 | 0.20 | -1.76 | Krystal Biotech misses top-line and bottom-line estimates; reaffirms FY24 outlook [5/6/2024 8:03 AM] |
156.86 | -4.24 (-2.63%) |
150.00 | -11.10 (-6.89%) |
83.38 - 189.97 | 722,236 | 270,000 | 36,875 | ||
| 26-02-2024 | PM | KRYS | Krystal Biotech, Inc. | 3,160 | 0.30 | -0.52 | -1.25 | Krystal Biotech GAAP EPS of $0.30 beats by $0.69, revenue of $42.1M beats by $12.17M [2/26/2024 8:02 AM] |
157.03 | 45.70 (41.05%) |
122.00 | 10.67 (9.58%) |
70.51 - 162.28 | 2,008,129 | 330,000 | 72,837 | ||
| 06-11-2023 | PM | KRYS | Krystal Biotech, Inc. | 3,330 | -0.67 | -1.10 | -1.17 | Krystal Biotech GAAP EPS of $2.79 beats by $3.46, revenue of $8.6M beats by $2.31M [11/6/2023 7:07 AM] |
103.85 | -18.30 (-14.98%) |
114.21 | -7.94 (-6.50%) |
69.81 - 132.68 | 1,411,187 | 280,000 | 1,658 | ||
| 07-08-2023 | PM | KRYS | Krystal Biotech | 3,480 | -1.25 | -0.42 | 0.00 | Krystal Biotech GAAP EPS of -$1.25 misses by $0.51 [8/7/2023 7:18 AM] |
108.93 | -15.27 (-12.29%) |
115.00 | -9.20 (-7.41%) |
61.11 - 131.80 | 1,035,963 | 190,000 | 1,013 | ||
| 07-11-2022 | PM | 7:00 AM ET (Nov 7) |
KRYS | Krystal Biotech | 1,877 | -1.17 | -1.23 | 0.00 | Krystal Biotech GAAP EPS of -$1.17 beats by $0.05 [11/7/2022 8:18 AM] |
78.41 | 5.20 (7.10%) |
73.21 | 0.0 (0.00%) |
38.86 - 102.99 | 113,803 | 160,000 | 8,695 | |
| 28-02-2022 | PM | KRYS | Krystal Biotech | 1,352 | -0.94 | -0.76 | 0.00 | Krystal Biotech GAAP EPS of -$3.13 misses by $2.40 [2/28/2022 7:16 AM] |
62.67 | 0.17 (0.27%) |
62.50 | 0.0 (0.00%) |
38.86 - 102.99 | 72,400 | 190,000 | 435 | ||
| 10-05-2021 | PM | KRYS | Krystal Biotech, Inc. | 1,710 | -0.74 | -0.55 | -0.31 | Krystal Biotech EPS misses by $0.16 [5/10/2021 8:17 AM] |
66.00 | -4.78 (-6.75%) |
70.78 | 0.0 (0.00%) |
37.68 - 87.29 | 89,878 | 90,000 | 2,135 | ||
| 01-03-2021 | PM | 8:00 AM ET (Mar 1) |
KRYS | Krystal Biotech, Inc. | 1,555 | -0.53 | -0.55 | 0.00 | Krystal Biotech reports Q4 results [3/1/2021 9:27 AM] |
84.84 | 5.95 (7.54%) |
78.89 | 0.0 (0.00%) |
33.08 - 87.29 | 198,040 | 195,570 | 3,582 | |
| 09-11-2020 | PM | KRYS | Krystal Biotech, Inc. | 854.01 | -0.49 | -0.44 | -0.25 | Krystal Biotech EPS misses by $0.04 [11/9/2020 8:16 AM] |
42.08 | 1.44 (3.54%) |
40.50 | -0.14 (-0.34%) |
33.08 - 66.85 | 202,078 | 144,963 | 394 | ||
|
|
||||||||||||||||||
| 10-08-2020 | PM | KRYS | Krystal Biotech, Inc. | 784.86 | -0.37 | -0.42 | -0.37 | Krystal Biotech EPS beats by $0.06 [8/10/2020 8:08 AM] |
42.28 | 1.10 (2.67%) |
41.18 | 0.0 (0.00%) |
31.89 - 66.85 | 65,173 | 150,023 | 1,828 | ||
|
|
||||||||||||||||||